{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:48:29Z","timestamp":1790858909456,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["20-54-56005"],"award-info":[{"award-number":["20-54-56005"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2033 \u2013 390677874 \u2013 RESOLV"],"award-info":[{"award-number":["EXC 2033 \u2013 390677874 \u2013 RESOLV"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["98029520"],"award-info":[{"award-number":["98029520"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    \u03b1-Synuclein (\u03b1-Syn) aggregates are key components of intracellular inclusion bodies characteristic of Parkinson\u2019s disease (PD) and other synucleinopathies. Metal ions have been considered as the important etiological factors in PD since their interactions with \u03b1-Syn alter the kinetics of fibrillation. In the present study, we have systematically explored the effects of Zn\n                    <jats:sup>2+<\/jats:sup>\n                    , Cu\n                    <jats:sup>2+<\/jats:sup>\n                    , Ca\n                    <jats:sup>2+<\/jats:sup>\n                    , and Mg\n                    <jats:sup>2+<\/jats:sup>\n                    cations on \u03b1-Syn fibril formation. Specifically, we determined fibrillation kinetics, size, morphology, and secondary structure of the fibrils and their cytotoxic activity. While all cations accelerate fibrillation, we observed distinct effects of the different ions. For example, Zn\n                    <jats:sup>2+<\/jats:sup>\n                    induced fibrillation by lower\n                    <jats:italic>t<\/jats:italic>\n                    <jats:sub>lag<\/jats:sub>\n                    and higher\n                    <jats:italic>k<\/jats:italic>\n                    <jats:sub>app<\/jats:sub>\n                    and formation of shorter fibrils, while Ca\n                    <jats:sup>2+<\/jats:sup>\n                    ions lead to formation of longer fibrils, as evidenced by dynamic light scattering and atomic force microscopy studies. Additionally, the morphology of formed fibrils was different. Circular dichroism and attenuated total reflection-Fourier transform infrared spectroscopies revealed higher contents of \u03b2-sheets in fibrils. Interestingly, cell viability studies indicated nontoxicity of \u03b1-Syn fibrils formed in the presence of Zn\n                    <jats:sup>2+<\/jats:sup>\n                    ions, while the fibrils formed in the presence of Cu\n                    <jats:sup>2+<\/jats:sup>\n                    , Ca\n                    <jats:sup>2+<\/jats:sup>\n                    , and Mg\n                    <jats:sup>2+<\/jats:sup>\n                    were cytotoxic. Our results revealed that \u03b1-Syn fibrils formed in the presence of different divalent cations have distinct structural and cytotoxic features.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-15472-4","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T07:07:00Z","timestamp":1657696020000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Bivalent metal ions induce formation of \u03b1-synuclein fibril polymorphs with different cytotoxicities"],"prefix":"10.1038","volume":"12","author":[{"given":"Deyhim","family":"Atarod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Mamashli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atiyeh","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faezeh","family":"Moosavi-Movahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Pirhaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Nedaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Muronetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Haertl\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Tatzelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamhossein","family":"Riazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Akbar","family":"Saboury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"15472_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0014-5793(94)00395-5","volume":"345","author":"R Jakes","year":"1994","unstructured":"Jakes, R., Spillantini, M. G. & Goedert, M. Identification of two distinct synucleins from human brain. FEBS Lett. 345, 27\u201332. https:\/\/doi.org\/10.1016\/0014-5793(94)00395-5 (1994).","journal-title":"FEBS Lett."},{"key":"15472_CR2","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. \u03b1-Synuclein in Lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"15472_CR3","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/pro.3684","volume":"28","author":"C Dong","year":"2019","unstructured":"Dong, C., Garen, C. R., Mercier, P., Petersen, N. O. & Woodside, M. T. Characterizing the inhibition of \u03b1-synuclein oligomerization by a pharmacological chaperone that prevents prion formation by the protein PrP. Protein Sci. 28, 1690\u20131702. https:\/\/doi.org\/10.1002\/pro.3684 (2019).","journal-title":"Protein Sci."},{"key":"15472_CR4","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1136\/jnnp.52.2.185","volume":"110","author":"W Gibb","year":"1987","unstructured":"Gibb, W., Esiri, M. & Lees, A. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 110, 1131\u20131153. https:\/\/doi.org\/10.1136\/jnnp.52.2.185 (1987).","journal-title":"Brain"},{"key":"15472_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1056\/NEJMra1311488","volume":"372","author":"A Fanciulli","year":"2015","unstructured":"Fanciulli, A. & Wenning, G. K. Multiple-system atrophy. N. Engl. J. Med. 372, 249\u2013263. https:\/\/doi.org\/10.1056\/NEJMra1311488 (2015).","journal-title":"N. Engl. J. Med."},{"key":"15472_CR6","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1073\/pnas.0407881102","volume":"102","author":"RM Rasia","year":"2005","unstructured":"Rasia, R. M. et al. Structural characterization of copper (II) binding to \u03b1-synuclein: Insights into the bioinorganic chemistry of Parkinson\u2019s disease. Proc. Natl. Acad. Sci. U.S.A. 102, 4294\u20134299. https:\/\/doi.org\/10.1073\/pnas.0407881102 (2005).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"15472_CR7","doi-asserted-by":"publisher","first-page":"13709","DOI":"10.1021\/bi961799n","volume":"35","author":"PH Weinreb","year":"1996","unstructured":"Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A. & Lansbury, P. T. NACP, a protein implicated in Alzheimer\u2019s disease and learning, is natively unfolded. Biochemistry 35, 13709\u201313715. https:\/\/doi.org\/10.1021\/bi961799n (1996).","journal-title":"Biochemistry"},{"key":"15472_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.biochi.2020.01.004","volume":"170","author":"M Medvedeva","year":"2020","unstructured":"Medvedeva, M. et al. Naturally occurring cinnamic acid derivatives prevent amyloid transformation of alpha-synuclein. Biochimie. 170, 128\u2013139. https:\/\/doi.org\/10.1016\/j.biochi.2020.01.004 (2020).","journal-title":"Biochimie."},{"key":"15472_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-03111-4","volume":"9","author":"J Lautenschl\u00e4ger","year":"2018","unstructured":"Lautenschl\u00e4ger, J. et al. C-terminal calcium binding of \u03b1-synuclein modulates synaptic vesicle interaction. Nat. Commun. 9, 1\u201313. https:\/\/doi.org\/10.1038\/s41467-018-03111-4 (2018).","journal-title":"Nat. Commun."},{"key":"15472_CR10","doi-asserted-by":"publisher","first-page":"44284","DOI":"10.1074\/jbc.M105343200","volume":"276","author":"VN Uversky","year":"2001","unstructured":"Uversky, V. N., Li, J. & Fink, A. L. Metal-triggered structural transformations, aggregation, and fibrillation of human \u03b1-synuclein: A possible molecular link between Parkinson\u2019s disease and heavy metal exposure. J. Biol. Chem. 276, 44284\u201344296. https:\/\/doi.org\/10.1074\/jbc.M105343200 (2001).","journal-title":"J. Biol. Chem."},{"key":"15472_CR11","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1110\/ps.0230903","volume":"12","author":"J Goers","year":"2003","unstructured":"Goers, J., Uversky, V. N. & Fink, A. L. Polycation-induced oligomerization and accelerated fibrillation of human \u03b1-synuclein in vitro. Protein Sci. 12, 702\u2013707. https:\/\/doi.org\/10.1110\/ps.0230903 (2003).","journal-title":"Protein Sci."},{"key":"15472_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bbrc.2007.05.060","volume":"359","author":"K Rao","year":"2007","unstructured":"Rao, K. Thermodynamics imprinting reveals differential binding of metals to \u03b1-synuclein: Relevance to Parkinson\u2019s disease. Biochem. Biophys. Res. Commun. 359, 115\u2013120. https:\/\/doi.org\/10.1016\/j.bbrc.2007.05.060 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"15472_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/BF00703209","volume":"59","author":"Y Kimula","year":"1983","unstructured":"Kimula, Y., Utsuyama, M., Yoshimura, M. & Tomonaga, M. Element analysis of Lewy and adrenal bodies in Parkinson\u2019s disease by electron probe microanalysis. Acta Neuropathol. 59, 233\u2013236. https:\/\/doi.org\/10.1007\/BF00703209 (1983).","journal-title":"Acta Neuropathol."},{"key":"15472_CR14","doi-asserted-by":"publisher","first-page":"6898","DOI":"10.1021\/ja711415b","volume":"130","author":"JC Lee","year":"2008","unstructured":"Lee, J. C., Gray, H. B. & Winkler, J. R. Copper (II) binding to \u03b1-synuclein, the Parkinson\u2019s protein. J. Am. Chem. Soc. 130, 6898\u20136899. https:\/\/doi.org\/10.1021\/ja711415b (2008).","journal-title":"J. Am. Chem. Soc."},{"key":"15472_CR15","doi-asserted-by":"publisher","first-page":"9893","DOI":"10.1021\/ja0618649","volume":"128","author":"A Binolfi","year":"2006","unstructured":"Binolfi, A. et al. Interaction of \u03b1-synuclein with divalent metal ions reveals key differences: A link between structure, binding specificity and fibrillation enhancement. J. Am. Chem. Soc. 128, 9893\u20139901. https:\/\/doi.org\/10.1021\/ja0618649 (2006).","journal-title":"J. Am. Chem. Soc."},{"key":"15472_CR16","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jinorgbio.2012.06.011","volume":"117","author":"AA Valiente-Gabioud","year":"2012","unstructured":"Valiente-Gabioud, A. A. et al. Structural basis behind the interaction of Zn2+ with the protein \u03b1-synuclein and the A\u03b2 peptide: A comparative analysis. J. Inorg. Biochem. 117, 334\u2013341. https:\/\/doi.org\/10.1016\/j.jinorgbio.2012.06.011 (2012).","journal-title":"J. Inorg. Biochem."},{"key":"15472_CR17","doi-asserted-by":"publisher","first-page":"22680","DOI":"10.1074\/jbc.M101181200","volume":"276","author":"MS Nielsen","year":"2001","unstructured":"Nielsen, M. S., Vorum, H., Lindersson, E. & Jensen, P. H. Ca2+ binding to \u03b1-synuclein regulates ligand binding and oligomerization. J. Biol. Chem. 276, 22680\u201322684. https:\/\/doi.org\/10.1074\/jbc.M101181200 (2001).","journal-title":"J. Biol. Chem."},{"key":"15472_CR18","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1110\/ps.04879704","volume":"13","author":"R Lowe","year":"2004","unstructured":"Lowe, R., Pountney, D. L., Jensen, P. H., Gai, W. P. & Voelcker, N. H. Calcium (II) selectively induces \u03b1-synuclein annular oligomers via interaction with the C-terminal domain. Protein Sci. 13, 3245\u20133252. https:\/\/doi.org\/10.1110\/ps.04879704 (2004).","journal-title":"Protein Sci."},{"key":"15472_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-20320-5","volume":"8","author":"JY Han","year":"2018","unstructured":"Han, J. Y., Choi, T. S. & Kim, H. I. Molecular role of Ca2+ and hard divalent metal cations on accelerated fibrillation and interfibrillar aggregation of \u03b1-synuclein. Sci. Rep. 8, 1\u201311. https:\/\/doi.org\/10.1038\/s41598-018-20320-5 (2018).","journal-title":"Sci. Rep."},{"key":"15472_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijbiomac.2015.06.030","volume":"80","author":"S Shariatizi","year":"2015","unstructured":"Shariatizi, S., Meratan, A. A., Ghasemi, A. & Nemat-Gorgani, M. Inhibition of amyloid fibrillation and cytotoxicity of lysozyme fibrillation products by polyphenols. Int. J. Biol. Macromol. 80, 95\u2013106. https:\/\/doi.org\/10.1016\/j.ijbiomac.2015.06.030 (2015).","journal-title":"Int. J. Biol. Macromol."},{"key":"15472_CR21","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1038\/nprot.2006.202","volume":"1","author":"NJ Greenfield","year":"2006","unstructured":"Greenfield, N. J. Using circular dichroism spectra to estimate protein secondary structure. Nat. Protoc. 1, 2876\u20132890. https:\/\/doi.org\/10.1038\/nprot.2006.202 (2006).","journal-title":"Nat. Protoc."},{"key":"15472_CR22","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1021\/acs.jpcb.1c08796","volume":"126","author":"P Arghavani","year":"2022","unstructured":"Arghavani, P. et al. Inhibiting mTTR aggregation\/fibrillation by a chaperone-like hydrophobic amino acid-conjugated SPION. J. Phys. Chem. B 126, 1640\u20131654. https:\/\/doi.org\/10.1021\/acs.jpcb.1c08796 (2022).","journal-title":"J. Phys. Chem. B"},{"key":"15472_CR23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nprot.2015.024","volume":"10","author":"H Yang","year":"2015","unstructured":"Yang, H., Yang, S., Kong, J., Dong, A. & Yu, S. Obtaining information about protein secondary structures in aqueous solution using Fourier transform IR spectroscopy. Nat. Protoc. 10, 382\u2013396. https:\/\/doi.org\/10.1038\/nprot.2015.024 (2015).","journal-title":"Nat. Protoc."},{"key":"15472_CR24","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1021\/bi991447r","volume":"39","author":"KA Conway","year":"2000","unstructured":"Conway, K. A., Harper, J. D. & Lansbury, P. T. Fibrils formed in vitro from \u03b1-synuclein and two mutant forms linked to Parkinson\u2019s disease are typical amyloid. Biochemistry 39, 2552\u20132563. https:\/\/doi.org\/10.1021\/bi991447r (2000).","journal-title":"Biochemistry"},{"key":"15472_CR25","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1110\/ps.9.10.1960","volume":"9","author":"M Bouchard","year":"2000","unstructured":"Bouchard, M., Zurdo, J., Nettleton, E. J., Dobson, C. M. & Robinson, C. V. Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy. Protein Sci. 9, 1960\u20131967. https:\/\/doi.org\/10.1110\/ps.9.10.1960 (2000).","journal-title":"Protein Sci."},{"key":"15472_CR26","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.2147\/IJN.S212387","volume":"14","author":"SST Gilan","year":"2019","unstructured":"Gilan, S. S. T. et al. \u03b1-synuclein interaction with zero-valent iron nanoparticles accelerates structural rearrangement into amyloid-susceptible structure with increased cytotoxic tendency. Int. J. Nanomed. 14, 4637. https:\/\/doi.org\/10.2147\/IJN.S212387 (2019).","journal-title":"Int. J. Nanomed."},{"key":"15472_CR27","doi-asserted-by":"publisher","first-page":"183776","DOI":"10.1016\/j.bbamem.2021.183776","volume":"1864","author":"R Zadali","year":"2021","unstructured":"Zadali, R. et al. A study on the interaction of the amyloid fibrils of \u03b1-synuclein and hen egg white lysozyme with biological membranes. Biochim. Biophys. Acta. 1864, 183776. https:\/\/doi.org\/10.1016\/j.bbamem.2021.183776 (2021).","journal-title":"Biochim. Biophys. Acta."},{"key":"15472_CR28","doi-asserted-by":"publisher","first-page":"128079","DOI":"10.1016\/j.molstruc.2020.128079","volume":"1211","author":"B Zhou","year":"2020","unstructured":"Zhou, B., Wang, L., Zhang, J., Liu, Y. & Zhong, M. Inhibition of aggregation and toxicity of \u03b1-synuclein in the presence of copper by an N-methylated peptide. J. Mol. Struct. 1211, 128079. https:\/\/doi.org\/10.1016\/j.molstruc.2020.128079 (2020).","journal-title":"J. Mol. Struct."},{"key":"15472_CR29","doi-asserted-by":"publisher","first-page":"11801","DOI":"10.1021\/ja803494v","volume":"130","author":"A Binolfi","year":"2008","unstructured":"Binolfi, A. et al. Site-specific interactions of Cu (II) with \u03b1 and \u03b2-synuclein: Bridging the molecular gap between metal binding and aggregation. J. Am. Chem. Soc. 130, 11801\u201311812. https:\/\/doi.org\/10.1021\/ja803494v (2008).","journal-title":"J. Am. Chem. Soc."},{"key":"15472_CR30","doi-asserted-by":"publisher","first-page":"10668","DOI":"10.1021\/ic1016752","volume":"49","author":"A Binolfi","year":"2010","unstructured":"Binolfi, A. et al. Bioinorganic chemistry of Parkinson\u2019s disease: structural determinants for the copper-mediated amyloid formation of alpha-synuclein. Inorg. Chem. 49, 10668\u201310679. https:\/\/doi.org\/10.1021\/ic1016752 (2010).","journal-title":"Inorg. Chem."},{"key":"15472_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep41051","volume":"7","author":"SJ Roeters","year":"2017","unstructured":"Roeters, S. J. et al. Evidence for intramolecular antiparallel beta-sheet structure in alpha-synuclein fibrils from a combination of two-dimensional infrared spectroscopy and atomic force microscopy. Sci. Rep. 7, 1\u201311. https:\/\/doi.org\/10.1038\/srep41051 (2017).","journal-title":"Sci. Rep."},{"key":"15472_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-16564-3","volume":"11","author":"AD Stephens","year":"2020","unstructured":"Stephens, A. D. et al. Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity. Nat. Commun. 11, 1\u201315. https:\/\/doi.org\/10.1038\/s41467-020-16564-3 (2020).","journal-title":"Nat. Commun."},{"key":"15472_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00401-016-1538-0","volume":"131","author":"M Brahic","year":"2016","unstructured":"Brahic, M. et al. Axonal transport and secretion of fibrillar forms of \u03b1-synuclein, A\u03b242 peptide and HTTExon 1. Acta Neuropathol. 131, 539\u2013548. https:\/\/doi.org\/10.1007\/s00401-016-1538-0 (2016).","journal-title":"Acta Neuropathol."},{"key":"15472_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-21937-3","volume":"12","author":"R Cascella","year":"2021","unstructured":"Cascella, R. et al. The release of toxic oligomers from \u03b1-synuclein fibrils induces dysfunction in neuronal cells. Nat. Commun. 12, 1\u201316. https:\/\/doi.org\/10.1038\/s41467-021-21937-3 (2021).","journal-title":"Nat. Commun."},{"key":"15472_CR35","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/emboj.2011.86","volume":"30","author":"UK Resenberger","year":"2011","unstructured":"Resenberger, U. K. et al. The cellular prion protein mediates neurotoxic signalling of \u03b2-sheet-rich conformers independent of prion replication. EMBO J. 30, 2057\u20132070. https:\/\/doi.org\/10.1038\/emboj.2011.86 (2011).","journal-title":"EMBO J."},{"key":"15472_CR36","doi-asserted-by":"publisher","first-page":"11845","DOI":"10.1002\/chem.202101592","volume":"27","author":"R Oliva","year":"2021","unstructured":"Oliva, R. et al. Remodeling of the fibrillation pathway of \u03b1-synuclein by interaction with antimicrobial peptide LL-III. Chem. Eur. J. 27, 11845\u201311851. https:\/\/doi.org\/10.1002\/chem.202101592 (2021).","journal-title":"Chem. Eur. J."},{"key":"15472_CR37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/s0022-2836(02)00775-1","volume":"322","author":"W Hoyer","year":"2002","unstructured":"Hoyer, W. et al. Dependence of \u03b1-synuclein aggregate morphology on solution conditions. J. Mol. Biol. 322, 383\u2013393. https:\/\/doi.org\/10.1016\/s0022-2836(02)00775-1 (2002).","journal-title":"J. Mol. Biol."},{"key":"15472_CR38","doi-asserted-by":"publisher","first-page":"183251","DOI":"10.1016\/j.bbamem.2020.183251","volume":"1862","author":"Z Dehghani","year":"2020","unstructured":"Dehghani, Z., Meratan, A. A., Saboury, A. A. & Nemat-Gorgani, M. \u03b1-Synuclein fibrillation products trigger the release of hexokinase I from mitochondria: Protection by curcumin, and possible role in pathogenesis of Parkinson\u2019s disease. Biochim. Biophys. Acta. 1862, 183251. https:\/\/doi.org\/10.1016\/j.bbamem.2020.183251 (2020).","journal-title":"Biochim. Biophys. Acta."},{"key":"15472_CR39","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/0003-2697(89)90046-8","volume":"177","author":"H Naiki","year":"1989","unstructured":"Naiki, H., Higuchi, K., Hosokawa, M. & Takeda, T. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T. Anal. Biochem. 177, 244\u2013249. https:\/\/doi.org\/10.1016\/0003-2697(89)90046-8 (1989).","journal-title":"Anal. Biochem."},{"key":"15472_CR40","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/polym12030517","volume":"12","author":"P Semenyuk","year":"2020","unstructured":"Semenyuk, P., Kurochkina, L., Barinova, K. & Muronetz, V. Alpha-synuclein amyloid aggregation is inhibited by sulfated aromatic polymers and pyridinium polycation. Polymers 12, 517. https:\/\/doi.org\/10.3390\/polym12030517 (2020).","journal-title":"Polymers"},{"key":"15472_CR41","doi-asserted-by":"publisher","first-page":"6036","DOI":"10.1021\/bi002555c","volume":"40","author":"L Nielsen","year":"2001","unstructured":"Nielsen, L. et al. Effect of environmental factors on the kinetics of insulin fibril formation: Elucidation of the molecular mechanism. Biochemistry 40, 6036\u20136046. https:\/\/doi.org\/10.1021\/bi002555c (2001).","journal-title":"Biochemistry"},{"key":"15472_CR42","doi-asserted-by":"publisher","first-page":"e0187841","DOI":"10.1371\/journal.pone.0187841","volume":"12","author":"M Mahdavimehr","year":"2017","unstructured":"Mahdavimehr, M. et al. Inhibition of HEWL fibril formation by taxifolin: Mechanism of action. PLoS One 12, e0187841. https:\/\/doi.org\/10.1371\/journal.pone.0187841 (2017).","journal-title":"PLoS One"},{"key":"15472_CR43","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1177\/37.8.2666510","volume":"37","author":"WE Klunk","year":"1989","unstructured":"Klunk, W. E., Pettegrew, J. & Abraham, D. J. Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J. Histochem. Cytochem. 37, 1273\u20131281. https:\/\/doi.org\/10.1177\/37.8.2666510 (1989).","journal-title":"J. Histochem. Cytochem."},{"key":"15472_CR44","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.taap.2016.10.021","volume":"313","author":"B Bigdeli","year":"2016","unstructured":"Bigdeli, B. et al. Enterolactone: A novel radiosensitizer for human breast cancer cell lines through impaired DNA repair and increased apoptosis. Toxicol. Appl. Pharmacol. 313, 180\u2013194. https:\/\/doi.org\/10.1016\/j.taap.2016.10.021 (2016).","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15472-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15472-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15472-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T02:10:23Z","timestamp":1669342223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15472-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["15472"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-15472-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]},"assertion":[{"value":"27 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11898"}}